Related references
Note: Only part of the references are listed.Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication
Ni Li et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Special Commentary Patient Safety and the Next Generation of HPV DNA Tests
Walter Kinney et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2010)
The Sensitivity and Specificity of p16INK4a Cytology vs HPV Testing for Detecting High-Grade Cervical Disease in the Triage of ASC-US and LSIL Pap Cytology Results
Karin J. Denton et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2010)
Cervical Cancer Screening With Both Human Papillomavirus and Papanicolaou Testing vs Papanicolaou Testing Alone What Screening Intervals Are Physicians Recommending?
Mona Saraiya et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
A randomized controlled trial of Human Papillomavirus (HPV) testing for cervical cancer screening: trial design and preliminary results (HPV FOCAL Trial)
Gina S. Ogilvie et al.
BMC CANCER (2010)
Behavioral/Lifestyle and Immunologic Factors Associated with HPV Infection among Women Older Than 45 Years
Paula Gonzalez et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Chlamydia trachomatis and Risk of Prevalent and Incident Cervical Premalignancy in a Population-Based Cohort
Mahboobeh Safaeian et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Longitudinal Study of Human Papillomavirus Persistence and Cervical Intraepithelial Neoplasia Grade 2/3: Critical Role of Duration of Infection
Ana Cecilia Rodriguez et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial
Guglielmo Ronco et al.
LANCET ONCOLOGY (2010)
Relationship of Atypical Glandular Cell Cytology, Age, and Human Papillomavirus Detection to Cervical and Endometrial Cancer Risks
Philip E. Castle et al.
OBSTETRICS AND GYNECOLOGY (2010)
The Age-Specific Relationships of Abnormal Cytology and Human Papillomavirus DNA Results to the Risk of Cervical Precancer and Cancer
Philip E. Castle et al.
OBSTETRICS AND GYNECOLOGY (2010)
Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments
Hans-Ulrich Bernard et al.
VIROLOGY (2010)
The Reproducibility of CIN Diagnoses Among Different Pathologists Data From Histology Reviews From a Multicenter Randomized Study
Paolo Dalla Palma et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2009)
Cost-Effectiveness of Human Papillomavirus Vaccination and Cervical Cancer Screening in Women Older Than 30 Years in the United States
Jane J. Kim et al.
ANNALS OF INTERNAL MEDICINE (2009)
The Expected Impact of HPV Vaccination on the Accuracy of Cervical Cancer Screening: The Need for a Paradigm Change
Eduardo L. Franco et al.
ARCHIVES OF MEDICAL RESEARCH (2009)
Persistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian women
N. Munoz et al.
BRITISH JOURNAL OF CANCER (2009)
Cancer Statistics, 2009
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study
Limin X. Clegg et al.
CANCER CAUSES & CONTROL (2009)
Persistence of an Incident Human Papillomavirus Infection and Timing of Cervical Lesions in Previously Unexposed Young Women
Helen Trottier et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Cervical Carcinoma and Sexual Behavior: Collaborative Reanalysis of Individual Data on 15,461 Women with Cervical Carcinoma and 29,164 Women without Cervical Carcinoma from 21 Epidemiological Studies
Paul Appleby et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions
Susanne K. Kjaer et al.
CANCER PREVENTION RESEARCH (2009)
p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: A systematic review and meta-analysis
I. Tsoumpou et al.
CANCER TREATMENT REVIEWS (2009)
High-risk human papillomavirus DNA load in a population-based cervical screening cohort in relation to the detection of high-grade cervical intraepithelial neoplasia and cervical cancer
Albertus T. Hesselink et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Screening and adenocarcinoma of the cervix
Peter Sasieni et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
EUROGIN 2008 roadmap on cervical cancer prevention
Silvia Franceschi et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Comparison of Liquid-Based Cytology With Conventional Cytology for Detection of Cervical Cancer Precursors A Randomized Controlled Trial
Albertus G. Siebers et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
The Accuracy of Colposcopic Grading for Detection of High-Grade Cervical Intraepithelial Neoplasia
L. Stewart Massad et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2009)
Human Papillomavirus Genotype Distributions: Implications for Vaccination and Cancer Screening in the United States
Cosette M. Wheeler et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Efficacy of HPV DNA Testing With Cytology Triage and/or Repeat HPV DNA Testing in Primary Cervical Cancer Screening
Pontus Naucler et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
J. Paovonen et al.
LANCET (2009)
Risk estimation for the next generation of prevention programmes for cervical cancer
Hormuzd A. Katki et al.
LANCET ONCOLOGY (2009)
HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial
Henry C. Kitchener et al.
LANCET ONCOLOGY (2009)
A review of human carcinogens-Part B: biological agents
Veronique Bouvard et al.
LANCET ONCOLOGY (2009)
HPV Screening for Cervical Cancer in Rural India
Rengaswamy Sankaranarayanan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The Use of Human Papillomavirus Seroepidemiology to Inform Vaccine Policy
Mark Schiffman et al.
SEXUALLY TRANSMITTED DISEASES (2009)
Human papillomavirus-related disease in people with HIV
Joel Palefsky
CURRENT OPINION IN HIV AND AIDS (2009)
Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline
Mark Schiffman et al.
Infectious Agents and Cancer (2009)
Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study
Philip E. Castle et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
A comparison of Linear Array and Hybrid Capture 2 for detection of carcinogenic human papillomavirus and cervical precancer in ASCUS-LSIL triage study
Patti E. Gravitt et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia
Kate Cuschieri et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Age-Specific Prevalence of Infection with Human Papillomavirus in Females: A Global Review
Jennifer S. Smith et al.
JOURNAL OF ADOLESCENT HEALTH (2008)
Human papillomavirus genotype specificity of Hybrid Capture 2
Philip E. Castle et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Risk of female human papillomavirus acquisition associated with first male sex partner
Rachel L. Winer et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections
Ana Cecilia Rodriguez et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Heterogeneity in CIN3 diagnosis
Mark Shiffman et al.
LANCET ONCOLOGY (2008)
Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial
Francesca Carozzi et al.
LANCET ONCOLOGY (2008)
Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study
Margaret R. E. McCredie et al.
LANCET ONCOLOGY (2008)
A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China
You-lin Qiao et al.
LANCET ONCOLOGY (2008)
Interobserver agreement in the assessment of components of colposcopic grading
L. Stewart Massad et al.
OBSTETRICS AND GYNECOLOGY (2008)
Cervical Cancer Screening in the Early Postvaccine Era
Alan G. Waxman
OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA (2008)
Modeling Cervical Cancer Prevention in Developed Countries
Jane J. Kim et al.
VACCINE (2008)
Epidemiology and Natural History of Human Papillomavirus Infections and Type-Specific Implications in Cervical Neoplasia
F. Xavier Bosch et al.
VACCINE (2008)
Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing Countries
Jack Cuzick et al.
VACCINE (2008)
New Technologies in Cervical Cancer Screening
Patti E. Gravitt et al.
VACCINE (2008)
Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study
Joalim Dillner et al.
BRITISH MEDICAL JOURNAL (2008)
High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease
Patti E. Gravitt et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial
N. W. J. Bulkmans et al.
LANCET (2007)
Inappropriate gold standard bias in cervical cancer screening studies
Robert G. Pretorius et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Cervical cancer and hormonal contraceptives:: Collaborative reanalysis of individual data for 16 573 women with cervical cancer and 35 509 women without cervical cancer from 24 epidemiological studies
Paul Appleby et al.
LANCET (2007)
Human papillomavirus DNA versus papanicolaou screening tests for cervical cancer
Marie-Helene Mayrand et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Human papillomavirus and papanicolaou tests to screen for cervical cancer
Pontus Naucler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ
Thomas C. Wright et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2007)
2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests
Thomas C. Wright et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2007)
CIN2 is a much less reproducible and less valid diagnosis than CIN3: Results from a histological review of population-based cervical samples
Joseph D. Carreon et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2007)
Risk assessment to guide the prevention of cervical cancer
Philip E. Castle et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2007)
Human papillomavirus and cervical cancer
Mark Schiffman et al.
LANCET (2007)
Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection - A randomized trial
Allan Hildesheim et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update
Jennifer S. Smith et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Risk of high-grade cervical intra-epithelial neoplasia based on cytology and high-risk HPV testing at baseline and at 6-months
Saskia Bulk et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial
Guglielmo Ronco et al.
BRITISH MEDICAL JOURNAL (2007)
Visual appearance of the uterine cervix: correlation with human papillomavirus detection and type
Jose Jeronimo et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2007)
Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing
Mark Schiffman
CANCER CYTOPATHOLOGY (2007)
A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion
Martyn Plummer et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Cervical cancer screening rates in the United States and the potential impact of implementation of screening guidelines
Diane Solomon et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2007)
Triage of women with ASCUS and LSIL cytology -: Use of qualitative assessment of p16INK4a positive cells to identify patients with high-grade ceivical intraepithelial neoplasia
Nicolas Wentzensen et al.
CANCER CYTOPATHOLOGY (2007)
HPV triage for low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytology
Guglielmo Ronco et al.
EUROPEAN JOURNAL OF CANCER (2007)
Viral determinants of human papillomavirus persistence following loop electrical excision procedure treatment for cervical Intraepithelial neoplasia grade 2 or 3
Aimee R. Kreimer et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Biomarkers in cervical cancer screening
Nicolas Wentzensen et al.
DISEASE MARKERS (2007)
Papillomavirus life cycle organization and biomarker selection
John Doorbar
DISEASE MARKERS (2007)
Variations in the age-specific curves of human papillomavirus prevalence in women worldwide
Silvia Franceschi et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Persistent human papillomavirus infection is associated with a generalized decrease in immune responsiveness in older women
Alfonso J. Garcia-Pineres et al.
CANCER RESEARCH (2006)
The up-to-date evidence on colposcopy practice and treatment of cervical intraepithelial neoplasia: The cochrane colposcopy & cervical cytopathology collaborative group (C5 group) approach
M. Kyrgiou et al.
CANCER TREATMENT REVIEWS (2006)
Cervical cytology of atypical squamous cells-cannot exclude high-grade squarnous intraepithelial lesion (ASC-H)
Mark E. Sherman et al.
CANCER CYTOPATHOLOGY (2006)
Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality
Melinda Butsch Kovacic et al.
CANCER RESEARCH (2006)
Cervical carcinoma and reproductive factors:: Collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies
P. Appleby et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Epidemiology and transmission dynamics of genital HPV infection
Ann N. Burchell et al.
VACCINE (2006)
Colposcopy at a crossroads
Jose Jeronimo et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2006)
Number of cervical biopsies and sensitivity of colposcopy
Julia C. Gage et al.
OBSTETRICS AND GYNECOLOGY (2006)
Clinical implications of human papillomavirus in head and neck cancers
Carole Fakhry et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: Mathematical modelling analyses
Ruanne V. Barnabas et al.
PLOS MEDICINE (2006)
Human papillomavirus testing following loop electrosurgical excision procedure identifies women at risk for posttreatment cervical intraepithelial neoplasia grade 2 or 3 disease
Aimee R. Kreimer et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis
M Kyrgiou et al.
LANCET (2006)
HPV-mediated cervical carcinogenesis: concepts and clinical implications
PJF Snijders et al.
JOURNAL OF PATHOLOGY (2006)
Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities
PE Castle et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice
MJ Khan et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
The carcinogenicity of human papillornavirus types reflects viral evolution
M Schiffman et al.
VIROLOGY (2005)
Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica
R Herrero et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Human papillomavirus genotype distribution in low-grade cervical lesions: Comparison by geographic region and with cervical cancer.
GM Clifford et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
A study of the impact of adding HPV types to cervical cancer screening and triage tests
M Schiffman et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Virologic versus cytologic triage of women with equivocal pap smears: A meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia
M Arbyn et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract
N Wentzensen et al.
CANCER RESEARCH (2004)
Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance: A two-year prospective study
R Guido et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2003)
American Cancer Society guideline for the early detection of cervical neoplasia and cancer
D Saslow et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2002)
Host and viral genetics and risk of cervical cancer: a review
A Hildesheim et al.
VIRUS RESEARCH (2002)
Human papillomavirus DNA remains detectable longer than related cervical cytologic abnormalities
M Schiffman et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Viral load of human papillomavirus and risk of CIN3 or cervical cancer
AT Lorincz et al.
LANCET (2002)
Papillomaviruses and cancer: From basic studies to clinical application
H zur Hausen
NATURE REVIEWS CANCER (2002)
The causal relation between human papillomavirus and cervical cancer
FX Bosch et al.
JOURNAL OF CLINICAL PATHOLOGY (2002)
Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia
NF Schlecht et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Interobserver reproducibility of cervical cytologic and histologic interpretations - Realistic estimates from the ASCUS-LSIL triage study
MH Stoler et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: A systematic review
K Nanda et al.
ANNALS OF INTERNAL MEDICINE (2000)
Share Paper
